Can Tolvaptan be reimbursed by medical insurance?

The original drug Tolvaptan has been approved by the State Food and Drug Administration and is sold under the trade name Sumika. It was subsequently included in the scope of Class B medical insurance through the medical insurance standards of the National Medical Insurance Bureau. However, the reimbursement ratio is different in different regions, and the price after reimbursement will be different. This drug will be sold in domestic pharmacies or hospitals. There are also domestically produced drugs produced by other pharmaceutical companies in China, and their drug ingredients are basically the same. The original drug Tolvaptan is also on the market overseas. There are also generic tolvaptan tablets produced in other countries. The price of 15mg*4 tablets produced by Indian pharmaceutical factories is around RMB 800 per box (the price may fluctuate due to the exchange rate).